Literature DB >> 28769256

ENTERIC FEVER - CULTURE AND SENSITIVITY PATTERN AND TREATMENT OUTCOME.

C H Gidvani1, Vipan Chandar2, D Raghunath3, R D Puri4, C G Wilson5, A Nagendra6.   

Abstract

One hundred cases of enteric fever in the age group of 6 months to 12 years were analysed with respect to culture sensitivity pattern and treatment outcome. Patients were divided into 5 treatment groups - chloramphenicol, amoxycillin, trimethoprim-sulfamethoxazole + furazolidine, gentamicin + cephalexin and ciprofloxacin. Out of 91 culture positive cases, 100% were sensitive to ciprofloxacin followed by gentamicin (84.9%), cephalexin (83.6%), furazolidine (36.6%), trimethoprim-sulfamethoxazole (34.1%), chloramphenicol (34.0%) and amoxycillin (23.8%). In 60 cases resistant to chloramphenicol, resistance to other drugs varied from 20 to 88.3%. The treatment response was 100% to ciprofloxacin, 72.7% to chloramphenicol, 50% to gentamicin + cephalexin, 38.5% to trimethoprim-sulfamethoxazole + furazolidine and 12.5% to amoxycillin. Out of 48 cases who did not respond to initial regimen, 33 were treated successfully with ciprofloxacin and remaining with other drug regimens. Time taken for defervescence was shortest with gentamicin + cephalexin (4.6±2.0 days) followed by ciprofloxacin (6.1±2.5 days) and chloramphenicol (6.4±3.5 days). There were 3 deaths in this study.

Entities:  

Keywords:  Clinical trials; Drug resistance microbial; Typhoid

Year:  2017        PMID: 28769256      PMCID: PMC5529895          DOI: 10.1016/S0377-1237(17)30934-6

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  18 in total

1.  Drug resistant typhoid fever (DRT)

Authors:  A K Malhotra; B Singh; S K Minocha; H Kapoor
Journal:  J Assoc Physicians India       Date:  1992-06

2.  Multidrug resistant typhoid fever: study of an outbreak in Calcutta.

Authors:  R K Arora; A Gupta; N M Joshi; V K Kataria; P Lall; A C Anand
Journal:  Indian Pediatr       Date:  1992-01       Impact factor: 1.411

3.  Multi drug resistant Salmonella typhi infection: clinical profile and therapy.

Authors:  P B Koul; M V Murali; P P Sharma; O P Ghai; V G Ramchandran; V Talwar
Journal:  Indian Pediatr       Date:  1991-04       Impact factor: 1.411

4.  Ciprofloxacin in the management of multiple drug resistant typhoid fever.

Authors:  S Sen; R S Goyal; R Dev
Journal:  Indian Pediatr       Date:  1991-04       Impact factor: 1.411

5.  The challenge of multi-drug resistant typhoid fever.

Authors:  M Singh
Journal:  Indian Pediatr       Date:  1991-04       Impact factor: 1.411

6.  Epidemic multiresistant enteric fever in eastern India.

Authors:  A C Anand; V K Kataria; W Singh; S K Chatterjee
Journal:  Lancet       Date:  1990-02-10       Impact factor: 79.321

7.  Clinical profile and outcome in enteric fever.

Authors:  A Sharma; G Gathwala
Journal:  Indian Pediatr       Date:  1993-01       Impact factor: 1.411

8.  Chloramphenicol resistant Salmonella typhi: therapeutic considerations.

Authors:  J Chandra; R K Marwaha; S Sachdeva
Journal:  Indian J Pediatr       Date:  1984 Sep-Oct       Impact factor: 1.967

9.  Evaluation of the bone marrow culture versus the blood culture for laboratory diagnosis of enteric fever.

Authors:  G C Mehta; B U Joshi; S S Tilak
Journal:  Indian J Med Sci       Date:  1984-02

10.  Ciprofloxacin in typhoid fever.

Authors:  A Bavdekar; M Chaudhari; S Bhave; A Pandit
Journal:  Indian J Pediatr       Date:  1991 May-Jun       Impact factor: 1.967

View more
  1 in total

1.  ENTERIC FEVER THE CHANGING SCENE.

Authors:  P C Sanchetee; S K Sharma; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2017-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.